WallStreetZenWallStreetZen

NASDAQ: VERO
Venus Concept Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their VERO stock forecasts and price targets.

Forecast return on equity

Is VERO forecast to generate an efficient return?

Company
-461.48%
Industry
17.8%
Market
262.63%
VERO's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is VERO forecast to generate an efficient return on assets?

Company
-13.77%
Industry
9.92%
VERO is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

VERO earnings per share forecast

What is VERO's earnings per share in the next 2 years based on estimates from 4 analysts?

Avg 1 year Forecast
-$18.00
Avg 2 year Forecast
-$4.67

VERO revenue forecast

What is VERO's revenue in the next 2 years based on estimates from 4 analysts?

Avg 1 year Forecast
$61.0M+1.51%
Avg 2 year Forecast
$67.1M+11.66%
VERO's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

VERO revenue growth forecast

How is VERO forecast to perform vs Medical Devices companies and vs the US market?

Company
1.51%
Industry
6.43%
Market
1,347.71%
VERO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
VERO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

VERO vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
VERO$2.19N/AN/A
BBLG$2.16N/AN/A
HIND$5.52$15.00+171.74%Strong Buy
NAOV$5.76N/AN/A
BJDX$2.28N/AN/A
View Top Medical Device Stocks

Venus Concept Stock Forecast FAQ

What is VERO's earnings growth forecast for 2025-2026?

(NASDAQ: VERO) Venus Concept's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 29.03%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 2,752.56%.

Venus Concept's earnings in 2025 is -$41,335,000.On average, 4 Wall Street analysts forecast VERO's earnings for 2025 to be -$33,469,791, with the lowest VERO earnings forecast at -$32,157,251, and the highest VERO earnings forecast at -$34,454,197.

In 2026, VERO is forecast to generate -$8,685,079 in earnings, with the lowest earnings forecast at -$8,344,488 and the highest earnings forecast at -$8,940,523.

If you're new to stock investing, here's how to buy Venus Concept stock.

What is VERO's revenue growth forecast for 2025-2026?

(NASDAQ: VERO) Venus Concept's forecast annual revenue growth rate of 1.51% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 6.43%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 1,347.71%.

Venus Concept's revenue in 2025 is $60,107,000.On average, 4 Wall Street analysts forecast VERO's revenue for 2025 to be $113,432,531, with the lowest VERO revenue forecast at $108,985,509, and the highest VERO revenue forecast at $116,769,657.

In 2026, VERO is forecast to generate $124,776,899 in revenue, with the lowest revenue forecast at $119,883,688 and the highest revenue forecast at $128,446,808.

What is VERO's forecast return on assets (ROA) for 2025-2026?

(NASDAQ: VERO) forecast ROA is -13.77%, which is lower than the forecast US Medical Devices industry average of 9.92%.

What is VERO's Earnings Per Share (EPS) forecast for 2025-2026?

(NASDAQ: VERO) Venus Concept's current Earnings Per Share (EPS) is -$45.20. On average, analysts forecast that VERO's EPS will be -$18.00 for 2025, with the lowest EPS forecast at -$17.30, and the highest EPS forecast at -$18.53. In 2026, VERO's EPS is forecast to hit -$4.67 (min: -$4.49, max: -$4.81).

What is VERO's forecast return on equity (ROE) for 2025-2026?

(NASDAQ: VERO) forecast ROE is -461.48%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.